Inventor · disambiguated record
Subhendu Mukherjee
Also filed as: MUKHERJEE SUBHENDU
11 granted patents·10 pending applications·16 citations·filing 2012–2024
84Inventor score
Files withAURIGENE DISCOVERY TECH LTD9AURIGENE ONCOLOGY LTD4ORION CORP4ABBVIE INC1CALDERWOOD DAVID J1
Top patents by PatentIndex Score
21 records- 0192US11174232B2Substituted heterocyclyl derivatives as CDK inhibitorsAURIGENE DISCOVERY TECH LTD·Filed 2020·Granted Nov 16, 2021·3 cites·14 claims
- 0288US10689347B2Substituted heterocyclyl derivatives as CDK inhibitorsAURIGENE DISCOVERY TECH LTD·Filed 2016·Granted Jun 23, 2020·4 cites·30 claims
- 0387US10336697B2Spiro[cyclobutane-1,3′-indolin]-2′-one derivatives as bromodomain inhibitorsORION CORP·Filed 2016·Granted Jul 2, 2019·6 cites·30 claims
- 0475US11186576B2Pyrazolo[1,5-A][1,3,5]triazine and pyrazolo[1,5-A]pyrimidine derivatives as CDK inhibitorsAURIGENE DISCOVERY TECH LTD·Filed 2016·Granted Nov 30, 2021·1 cites·22 claims
- 0573US9447091B2Protein kinase inhibitorsORION CORP·Filed 2012·Granted Sep 20, 2016·2 cites·15 claims
- 0671US2024270734A1Pyridazine Derivatives as SMARCA2/4 DegradersAURIGENE ONCOLOGY LTD·Filed 2024·Application pending·0 cites
- 0770US12331023B2Substituted heterocyclyl derivatives as CDK inhibitorsAURIGENE ONCOLOGY LTD·Filed 2021·Granted Jun 17, 2025·0 cites·95 claims
- 0864US2022281871A1Pyrazolo[1,5-A][1,3,5]Triazine and Pyrazolo[1,5-A]Pyrimidine Derivatives as CDK InhibitorsAURIGENE DISCOVERY TECH LTD·Filed 2021·Application pending·0 cites
- 0959US12371426B2Pyridazine derivatives as SMARCA2/4 degradersAURIGENE DISCOVERY TECH LTD·Filed 2019·Granted Jul 29, 2025·0 cites·118 claims
- 1059US10391082B2Protein kinase inhibitorsORION CORP·Filed 2018·Granted Aug 27, 2019·0 cites·6 claims
- 1157US2025163049A1Fused bicyclic heterocyclyl compounds as usp1 inhibitorsEXELIXIS INC·Filed 2023·Application pending·0 cites
- 1254US2025145609A13-substituted pyridazine compounds as smarca2 and/or smarca4 degradersAURIGENE ONCOLOGY LTD·Filed 2023·Application pending·0 cites
- 1352US10894786B2Substituted pyrazole derivatives as selective CDK12/13 inhibitorsAURIGENE DISCOVERY TECH LTD·Filed 2019·Granted Jan 19, 2021·0 cites·25 claims
- 1450US2023322724A1Heterocyclic compounds as cbp/ep300 bromodomain inhibitorsAURIGENE ONCOLOGY LTD·Filed 2021·Application pending·0 cites
- 1549US2023212142A9Substituted 5-Cyclopropyl-1H-pyrazole-3-yl-amine Derivatives as Selective CDK12/13 InhibitorsAURIGENE DISCOVERY TECH LTD·Filed 2020·Application pending·0 cites
- 1648US2016346254A1Protein kinase inhibitorsORION CORP·Filed 2016·Application pending·0 cites
- 1742US9029409B2Isoxazolines as therapeutic agentsCALDERWOOD DAVID J·Filed 2012·Granted May 12, 2015·0 cites·17 claims
- 1840US12428415B2Matriptase 2 inhibitors and uses thereofDISC MEDICINE INC·Filed 2019·Granted Sep 30, 2025·0 cites·32 claims
- 1937US2015297596A1Isoxazolines as therapeutic agentsABBVIE INC·Filed 2015·Application pending·0 cites
- 2037US2018208605A1Substituted Aza Compounds as IRAK-4 InhibitorsAURIGENE DISCOVERY TECH LTD·Filed 2016·Application pending·0 cites
- 2136US2018201609A1Indazole and azaindazole compounds as irak-4 inhibitorsAURIGENE DISCOVERY TECH LTD·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Subhendu Mukherjee files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →